文献速递心境障碍

德国重性抑郁障碍患者与对照者白质微结构与认知下降的关联:一项前瞻性病例对照队列研究

Associations between white matter microstructure and cognitive decline in major depressive disorder versus controls in Germany: a prospective case-control cohort study.
PubMed 文献 · Lancet Psychiatry · 2024-01-01

在德国开展的自然观察性前瞻性病例对照队列研究中,418例重性抑郁障碍(MDD)患者与463名健康对照在基线和平均2.20年随访时接受弥散加权成像和神经心理测验。MDD患者认知表现低于对照,其上纵束白质完整性随时间下降更陡,且白质完整性下降与认知下降相关;在MDD患者中,白质完整性变化和不良抑郁病程独立预测随访时较低认知表现。

要点

  • MDD患者认知表现低于健康对照(p<0.0001,sr2=0.056),不随时间点改变。
  • MDD患者上纵束白质完整性随时间下降较健康对照更陡(ptfce-FWE=0.026,sr2=0.002)。
  • 在白质完整性下降与认知下降的关联跨两组稳健(ptfce-FWE<0.0001,sr2=0.004)。

核心结论

  • MDD患者白质完整性随时间改变的程度大于健康对照,且白质完整性下降与认知表现下降相关。
  • 作者认为白质微结构和疾病进展在抑郁相关认知功能障碍中起关键作用,两者均为未来治疗开发的重点目标。

研究设计与样本

  • 自然观察性前瞻性病例对照队列研究(Marburg-Münster情感障碍队列研究)的子样本分析。
  • 从德国Münster和Marburg当地精神病医院及报纸广告招募18-65岁白人参与者,纳入MDD患者和无任何精神障碍史的健康对照。
  • 基线和2年随访时收集弥散加权成像、神经心理测验组合和详细临床数据,采用线性混合效应模型比较两组认知表现和白质完整性的变化。
  • 弥散加权成像分析采用基于纤维束的空间统计,多重比较采用无阈值簇增强(TFCE)在家庭wise误差率(FWE)水平校正α值(ptfce-FWE),效应量以条件部分R2值(sr2)估计。
  • 分析认知表现变化与白质完整性变化的关联,并检验两次评估间抑郁病程是否预测随访时认知表现及白质完整性是否中介该关联。

主要发现

  • 共881名参与者,其中418名(47%)为MDD患者(平均年龄36.8岁[SD 13.4],274名[66%]女性,144名[34%]男性),463名(53%)为健康对照(平均年龄35.6岁[13.5],295名[64%]女性,168名[36%]男性)。
  • 基线评估于2014年9月11日至2019年6月3日完成,平均随访2.20年(SD 0.19)后,随访评估于2016年10月6日至2021年5月31日完成。
  • MDD患者认知表现低于健康对照(p<0.0001,sr2=0.056),无论时间点如何。
  • 弥散加权成像分析显示显著的诊断×时间交互作用,MDD患者上纵束白质完整性随时间下降较健康对照更陡(ptfce-FWE=0.026,sr2=0.002)。
  • 认知下降与白质完整性下降随时间稳健相关,跨两组(ptfce-FWE<0.0001,sr2=0.004)。

关键数值与推荐

  • MDD患者认知表现低于健康对照:p<0.0001,sr2=0.056。
  • MDD患者较健康对照上纵束白质完整性随时间下降更陡:诊断×时间交互ptfce-FWE=0.026,sr2=0.002。
  • 白质完整性下降与认知下降的关联跨两组:ptfce-FWE<0.0001,sr2=0.004。
  • MDD患者中白质完整性变化预测随访时较低认知表现:p=0.0040,β=0.071。
  • MDD患者中不良抑郁病程预测随访时较低认知表现:p=0.0022,β=-0.073。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cognitive deficits are a key source of disability in individuals with major depressive disorder (MDD) and worsen with disease progression. Despite their clinical relevance, the underlying mechanisms of cognitive deficits remain poorly elucidated, hampering effective treatment strategies. Emerging evidence suggests that alterations in white matter microstructure might contribute to cognitive dysfunction in MDD. We aimed to investigate the complex association between changes in white matter integrity, cognitive decline, and disease course in MDD in a comprehensive longitudinal dataset. METHODS: In the naturalistic, observational, prospective, case-control Marburg-Münster Affective Disorders Cohort Study, individuals aged 18-65 years and of Caucasian ancestry were recruited from local psychiatric hospitals in Münster and Marburg, Germany, and newspaper advertisements. Individuals diagnosed with MDD and individuals without any history of psychiatric disorder (ie, healthy controls) were included in this subsample analysis. Participants had diffusion-weighted imaging, a battery of neuropsychological tests, and detailed clinical data collected at baseline and at 2 years of follow-up. We used linear mixed-effect models to compare changes in cognitive performance and white matter integrity between participants with MDD and healthy controls. Diffusion-weighted imaging analyses were conducted using tract-based spatial statistics. To correct for multiple comparisons, threshold free cluster enhancement (TFCE) was used to correct α-values at the family-wise error rate (FWE; ptfce-FWE). Effect sizes were estimated by conditional, partial R2 values (sr2) following the Nakagawa and Schielzeth method to quantify explained variance. The association between changes in cognitive performance and changes in white matter integrity was analysed. Finally, we examined whether the depressive disease course between assessments predicted cognitive performance at follow-up and whether white matter integrity mediated this association. People with lived experience were not involved in the research and writing process. FINDINGS: 881 participants were selected for our study, of whom 418 (47%) had MDD (mean age 36·8 years [SD 13·4], 274 [66%] were female, and 144 [34%] were male) and 463 (53%) were healthy controls (mean age 35·6 years [13·5], 295 [64%] were female, and 168 [36%] were male). Baseline assessments were done between Sept 11, 2014, and June 3, 2019, and after a mean follow-up of 2·20 years (SD 0·19), follow-up assessments were done between Oct 6, 2016, and May 31, 2021. Participants with MDD had lower cognitive performance than did healthy controls (p<0·0001, sr2=0·056), regardless of timepoint. Analyses of diffusion-weighted imaging indicated a significant diagnosis × time interaction with a steeper decline in white matter integrity of the superior longitudinal fasciculus over time in participants with MDD than in healthy controls (ptfce-FWE=0·026, sr2=0·002). Furthermore, cognitive decline was robustly associated with the decline in white matter integrity over time across both groups (ptfce-FWE<0·0001, sr2=0·004). In participants with MDD, changes in white matter integrity (p=0·0040, β=0·071) and adverse depressive disease course (p=0·0022, β=-0·073) independently predicted lower cognitive performance at follow-up. INTERPRETATION: Alterations of white matter integrity occurred over time to a greater extent in participants with MDD than in healthy controls, and decline in white matter integrity was associated with a decline in cognitive performance across groups. Our findings emphasise the crucial role of white matter microstructure and disease progression in depression-related cognitive dysfunction, making both priority targets for future treatment development. FUNDING: German Research Foundation (DFG).

来源:Lancet Psychiatry,查看原文。版权归原作者所有。

引用

  1. Flinkenflügel K, Meinert S, Hirtsiefer C, et al. Associations between white matter microstructure and cognitive decline in major depressive disorder versus controls in Germany: a prospective case-control cohort study. Lancet Psychiatry. 2024. PMID: 39419563. doi:10.1016/S2215-0366(24)00291-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。